These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30636303)

  • 21. Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses.
    Larance B; Degenhardt L; Peacock A; Gisev N; Mattick R; Colledge S; Campbell G
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S203-S205. PubMed ID: 29024092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combating an Epidemic of Prescription Opioid Abuse.
    Pon D; Awuah K; Curi D; Okyere E; Stern CS
    J Calif Dent Assoc; 2015 Nov; 43(11):673-8. PubMed ID: 26798885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond the paper trail: using technology to reduce escalating harms from opioid prescribing in Australia.
    Nicholas R; Roche A; Dobbin M; Lee N
    Aust N Z J Public Health; 2013 Apr; 37(2):139-47. PubMed ID: 23551472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A changing landscape of opioid prescribing in emergency medicine.
    Griggs CA; Schulz CJ
    Am J Emerg Med; 2019 Feb; 37(2):327-328. PubMed ID: 30385189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disciplinary proceedings for inappropriate prescription of opioid medications by medical practitioners in Australia (2010-2014).
    Mendelson D
    J Law Med; 2014 Dec; 22(2):255-79. PubMed ID: 25715529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia.
    Hall WD; Farrell MP
    Med J Aust; 2011 Sep; 195(5):248-9. PubMed ID: 21895579
    [No Abstract]   [Full Text] [Related]  

  • 28. Prescription Monitoring Reduces Opioid Abuse, Deaths.
    Robertson D
    J Ark Med Soc; 2017 Jan; 113(7):156-157. PubMed ID: 30085460
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of prescription opioid abuse: the role of the dentist.
    Denisco RC; Kenna GA; O'Neil MG; Kulich RJ; Moore PA; Kane WT; Mehta NR; Hersh EV; Katz NP
    J Am Dent Assoc; 2011 Jul; 142(7):800-10. PubMed ID: 21719802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic Literature Review of Prescription Drug Monitoring Programs.
    Ponnapalli A; Grando A; Murcko A; Wertheim P
    AMIA Annu Symp Proc; 2018; 2018():1478-1487. PubMed ID: 30815193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iatrogenic Opioid Dependence in the United States: Are Surgeons the Gatekeepers?
    Waljee JF; Li L; Brummett CM; Englesbe MJ
    Ann Surg; 2017 Apr; 265(4):728-730. PubMed ID: 27429023
    [No Abstract]   [Full Text] [Related]  

  • 32. The FDA's Approach to the Prescription Opioid Problem.
    Woodcock J; Throckmorton DC
    Clin Pharmacol Ther; 2018 Jun; 103(6):954-955. PubMed ID: 29570773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid Use and Pain Control After Total Hip and Knee Arthroplasty in the US, 2014 to 2017.
    Shah R; Kuo YF; Westra J; Lin YL; Raji MA
    JAMA Netw Open; 2020 Jul; 3(7):e2011972. PubMed ID: 32729917
    [No Abstract]   [Full Text] [Related]  

  • 34. The rampant abuse of prescription pain medications.
    Falkowski C
    Minn Med; 2013 Mar; 96(3):38-41. PubMed ID: 23930468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving opioid prescribing: the New York City recommendations.
    Juurlink DN; Dhalla IA; Nelson LS
    JAMA; 2013 Mar; 309(9):879-80. PubMed ID: 23462783
    [No Abstract]   [Full Text] [Related]  

  • 36. Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates.
    Dowell D; Zhang K; Noonan RK; Hockenberry JM
    Health Aff (Millwood); 2016 Oct; 35(10):1876-1883. PubMed ID: 27702962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canada's prescription opioid epidemic grows despite tamperproof pills.
    Dyer O
    BMJ; 2015 Sep; 351():h4725. PubMed ID: 26338104
    [No Abstract]   [Full Text] [Related]  

  • 38. Foundations of opioid risk management.
    Katz NP; Adams EH; Benneyan JC; Birnbaum HG; Budman SH; Buzzeo RW; Carr DB; Cicero TJ; Gourlay D; Inciardi JA; Joranson DE; Kesslick J; Lande SD
    Clin J Pain; 2007 Feb; 23(2):103-18. PubMed ID: 17237659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
    Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
    J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuing education in opioid prescribing.
    Grabois M; Webster LR
    JAMA; 2012 Nov; 308(20):2082; author reply 2082-3. PubMed ID: 23188019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.